SPI-62

· Sparrow Pharmaceuticals

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SPI-62, covering 2025-05-11 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor [Phase 2]